Enhanced Recovery After Surgery began as a colorectal surgery protocol in 2005. Twenty years later, the ERAS Society has published procedure-specific guidelines covering nearly every major surgical specialty. For anaesthesiologists, the challenge has been fragmentation: each guideline is written for its own surgical audience, and the anaesthetic recommendations are scattered across dozens of documents.
A 2026 systematic review in the British Journal of Anaesthesia changed that. Bornemann-Cimenti and colleagues screened all ERAS Society guidelines published between 2013 and 2025, extracting every anaesthesiological recommendation and classifying them against 45 umbrella terms. Of 39 publications, 24 guidelines were included in the final analysis. The result: a consistent anaesthesiological core does exist — eight domains that appear across guidelines with >80% consistency, plus ten more that are mostly consistent (60–80%).
Why this matters
The anaesthesiologist sitting in the room doesn't need five separate ERAS documents. They need to know: what is non-negotiable, what is procedure-specific, and where the evidence is weak enough to justify local adaptation. This guide provides all three — a universal core, a specialty-by-specialty breakdown, and explicit gaps where the guideline strength is low but the recommendation remains strong.
How to read the tags in this guide
Strong means the panel recommends this for most patients. Recommend means it is advised where circumstances allow. Consensus reflects expert agreement where high-quality evidence is limited. New 2025 marks what entered the guideline for the first time. Emphasis Shift tracks where the philosophy changed materially. Evidence Gap marks where the recommendation is strong but the underlying evidence quality is low or very low — these are the areas most in need of local judgment and structured audit.
The universal anaesthesiological core: eight consistently represented domains
Across 24 procedure-specific guidelines published over twelve years, eight anaesthesiological domains were recommended consistently in more than 80% of guidelines. These are the domains most consistently represented across ERAS guidelines and therefore form the transposable anaesthesiological core.
| Domain | What the guidelines consistently recommend | Consistency |
|---|---|---|
| Multimodal analgesia | Opioid-sparing, multimodal approach using paracetamol, NSAIDs, regional techniques, and adjuncts. Opioids are rescue, not foundation. | Consistent (>80%) |
| Preoperative fasting | Shortened fasting: clear fluids up to 2 hours, solids up to 6 hours before anaesthesia. Prolonged overnight fasting is discouraged when contemporary fasting recommendations can be safely followed. | Consistent (>80%) |
| Thromboprophylaxis | Mechanical plus pharmacological prophylaxis based on risk stratification. Timing and agent are procedure-specific. | Consistent (>80%) |
| Antimicrobial prophylaxis | Timed preoperative antibiotics, typically within 60 minutes of incision. Redosing for prolonged surgery. | Consistent (>80%) |
| Nutrition | Preoperative carbohydrate loading where not contraindicated; early oral intake postoperatively; avoidance of prolonged starvation. | Consistent (>80%) |
| Temperature management | Active warming to maintain normothermia (≥36°C). Forced-air warming, warmed fluids, raised ambient temperature. | Consistent (>80%) |
| Fluid management | Goal-directed, balanced crystalloids. Avoid both hypovolaemia and excessive fluid administration. The 2025 colorectal guideline moved away from a strict near-zero-balance target toward avoidance of both extremes, with individualized goal-directed management. | Consistent (>80%) |
| Surgery-specific recommendations | Each guideline includes procedure-specific modifications to the core (e.g., epidural vs. TAP block, drain management, early feeding protocols). | Consistent (>80%) |
The eight consistent domains identified in the BJA systematic review. These form the transposable anaesthesiological core across ERAS guidelines.
Fluid management warrants special attention. Although it appears consistently across guidelines, the recommendation strength is often mixed. The 2025 colorectal guideline explicitly moved away from a strict "near-zero balance" strategy toward avoidance of both hypovolaemia and excessive fluid administration, reflecting new evidence that overly restrictive fluid regimens may impair tissue perfusion and gastrointestinal recovery. The BJA review identified fluid management, preoperative carbohydrate administration, and preanaesthetic medication as the three domains where consistency is high but recommendation strength varies most — these require structured local appraisal.
The 2025 colorectal guideline is the first full de novo rewrite since the original 2005 consensus, not a simple update. It introduces a new, more rigorous methodology and explicitly separates anaesthetic recommendations from surgical ones. The most consequential changes for anaesthesiologists involve fluid management, epidural analgesia, and cerebral monitoring.
Fluid management: The 2025 guideline moves away from a strict near-zero-balance target toward avoidance of both hypovolaemia and excessive fluid administration, with individualized goal-directed management. Balanced crystalloids are preferred. The guideline specifies maintaining slightly positive balance (≤2.5 kg weight gain).
Epidural analgesia in minimally invasive surgery: The 2025 guideline abandons routine thoracic epidural anaesthesia (TEA) in minimally invasive colorectal surgery in favour of multimodal analgesia. TEA remains appropriate for open surgery where the incision demands it, but for laparoscopic and robotic approaches the risks (hypotension, urinary retention, delayed mobilisation) now outweigh the benefits.
Anaesthetic considerations: The guideline discusses short-acting agents, tailored depth of anaesthesia with cerebral function monitoring (pEEG) where available, and antiadrenergic and anti-inflammatory strategies to reduce surgical stress. Hypotension should be avoided. These are anaesthetic considerations within the ERAS framework — they should be individualised to patient and procedural factors rather than applied as a fixed protocol.
Preoperative preparation
- Fasting: Clear fluids until 2 hours before anaesthesia; solids until 6 hours. Prolonged overnight fasting is discouraged when contemporary fasting recommendations can be safely followed.
- Carbohydrate loading: Clear carbohydrate drink the evening before and 2 hours before anaesthesia, unless contraindicated (severe diabetes, gastric emptying delay).
- Preanaesthetic medication: Routine anxiolytic premedication is not recommended; short-acting agents may be considered for specific patients. This domain was identified in the BJA review as having mixed-strength recommendations across guidelines.
- Preoperative optimisation: Anaemia correction, smoking cessation, nutritional assessment, and management of coexisting comorbidity should be completed before the day of surgery.
Intraoperative anaesthetic considerations
- Induction: Propofol or volatile induction; short-acting neuromuscular blockade with sugammadex reversal available.
- Maintenance: Volatile or TIVA; depth guided by pEEG where available. Avoid deep anaesthesia.
- Analgesia: Multimodal — paracetamol, NSAIDs (unless contraindicated), regional techniques as appropriate (TAP block, ESP block, or TEA for open surgery), and opioid rescue.
- Fluids: Goal-directed, balanced crystalloids; avoid both hypovolaemia and excessive administration.
- Temperature: Active warming to maintain ≥36°C.
- PONV: Multimodal prophylaxis for high-risk patients.
The 2025 cesarean update is the first revision of the intraoperative ERAS recommendations since 2018. It defines ten intraoperative intervention categories, all graded as strong recommendations — despite evidence quality ranging from very low to moderate. For the obstetric anaesthesiologist, the key domains are spinal hypotension prevention, antiemetic prophylaxis, multimodal analgesia, and uterotonic optimisation.
| Intervention | Recommendation | Evidence quality | Strength |
|---|---|---|---|
| Personal support persons | Allow a support person in the operating room | Very low | Strong |
| Prophylactic antibiotics | Before incision, appropriate agent | Moderate–high | Strong |
| Abdominal/vaginal preparation | Antiseptic preparation of abdomen and vagina | Moderate | Strong |
| Antiemetic prophylaxis | Multimodal, including dexamethasone and 5-HT₃ antagonist | Low | Strong |
| Prevention of spinal hypotension | Vasopressor infusion (phenylephrine preferred) started concurrently with spinal; fluid co-loading | Low | Strong |
| Normothermia | Active warming; forced-air and warmed fluids | Moderate | Strong |
| Euvolemia | Avoid fluid overload; balanced crystalloid, not excess | Low | Strong |
| Uterotonics | Optimal use — oxytocin first-line, with escalation protocol | Moderate | Strong |
| Multimodal analgesia | Intrathecal morphine + paracetamol + NSAID + opioid rescue | Low | Strong |
| Early skin-to-skin care | Initiate immediately after delivery if mother and baby stable | Moderate | Strong |
The ten intraoperative ERAS recommendations for cesarean delivery. All are strong recommendations, but note the low evidence quality underlying spinal hypotension prevention, antiemetic prophylaxis, and multimodal analgesia.
Practical interpretation: preventing spinal hypotension
A commonly used approach is prophylactic phenylephrine infusion with crystalloid co-loading, titrated to maintain maternal blood pressure. The guideline supports prevention of spinal hypotension and identifies vasopressor use and fluid management as important components, but exact dosing should follow local obstetric anaesthesia protocols. The steps below illustrate a widely used clinical approach — they are not prescriptive ERAS dosing.
Multimodal analgesia for cesarean
The ERAS guideline supports a multimodal approach including neuraxial morphine, paracetamol, NSAIDs, and opioid rescue. The specific agents and doses below illustrate a commonly used institutional approach — they are not ERAS-prescribed doses and should be adapted to local protocols and patient factors.
- Intrathecal morphine: Provides prolonged analgesia. Monitor for respiratory depression — especially in patients with obesity or sleep apnoea. Dosing per local protocol.
- Paracetamol: Scheduled dosing, per local protocol.
- NSAID: Scheduled dosing, per local protocol, unless contraindicated.
- Opioid rescue: Oxycodone or morphine for breakthrough pain. Avoid codeine in breastfeeding mothers (CYP2D6 ultra-rapid metaboliser risk).
- Dexamethasone: Serves dual purpose for PONV and analgesia; dosing per local protocol.
The cardiac surgery ERAS consensus is the newest addition to the ERAS family, developed by a multidisciplinary panel including cardiac surgeons, anaesthesiologists, intensivists, and nurses. It defines 24 ERAS measures grouped into five perioperative phases. For the cardiac anaesthesiologist, the most relevant domains are opioid-sparing multimodal analgesia, lung-protective ventilation, early extubation, and preoperative carbohydrate loading.
Opioid-sparing multimodal analgesia: Minimise intraoperative opioids and use shorter-acting anaesthetics. In a separate cardiac ERAS implementation study, total opioid consumption was 57% lower (259 vs 452 MME) with an ERAS rollout featuring gabapentin, lidocaine infusion, and regular paracetamol/NSAIDs. Parasternal plane blocks and erector spinae plane blocks are increasingly used as regional adjuncts. (The 57% figure comes from an implementation study, not the consensus statement itself.)
Lung-protective ventilation: Low tidal volume (6–8 mL/kg predicted body weight), PEEP 5–8 cmH₂O, and recruitment manoeuvres as needed. This is recommended for all cardiac surgical patients, not just those with pre-existing lung disease.
Preoperative carbohydrate loading: 800 mL of a 12.5% carbohydrate clear drink the night before and 400 mL of the same fluid 2 hours before surgery, except for patients with severe diabetes or known gastric emptying delay. Commercial formulations vary — the volumes and concentrations above reflect the commonly cited ERAS cardiac regimen.
Anaesthetic agents: Propofol-based anaesthesia is incorporated into ERAS cardiac pathways, although anaesthetic technique should be individualised to patient and procedural factors. Dexamethasone and ondansetron are standard components.
The cardiac ERAS bundle: what the anaesthesiologist owns
Perioperative cardiac ERAS — anaesthetic checklist
- Carbohydrate loading (unless contraindicated)
- Anaemia optimisation — iron studies, consider IV iron
- Smoking cessation ≥4 weeks
- Glycaemic control optimisation
- Prehabilitation where feasible
- Propofol-based anaesthesia (individualised)
- Dexamethasone at induction
- Lung-protective ventilation
- Opioid-sparing multimodal analgesia
- Goal-directed fluid therapy
- Active warming — maintain normothermia
- Ondansetron at end of surgery
- Early extubation in theatre or within 6 hours (fast-track)
- Multimodal analgesia: paracetamol, NSAID, gabapentinoid, lidocaine infusion
- Early mobilisation within 24 hours
- Early oral intake
The 2026 gynecologic oncology update is the third revision of the ERAS Society guideline for this specialty. It emphasises opioid-sparing multimodal anaesthesia and introduces the concept of same-day discharge for selected patients — a significant shift from the traditional overnight admission paradigm.
Opioid-sparing multimodal anaesthesia: The guideline emphasises opioid-sparing postoperative analgesia, including restrictive or no-opioid discharge prescribing, as a core component of the ERAS pathway. Multimodal strategies include paracetamol, NSAIDs, dexamethasone, and regional techniques where appropriate (TAP block, ESP block, or wound infiltration).
Same-day discharge: Same-day discharge is supported for selected patients undergoing minimally invasive gynecologic oncology surgery when appropriate clinical and system criteria are met. This requires preoperative education, a clear discharge protocol, and reliable follow-up. Anaesthetic considerations include using short-acting agents, avoiding long-acting opioids, and ensuring PONV prophylaxis is robust.
Anaesthetic protocol for gynecologic oncology
- Fasting: Clear fluids until 2 hours; solids until 6 hours.
- Carbohydrate loading: As per universal core.
- Premedication: Avoid routine anxiolytics; consider short-acting agents for specific patients.
- Induction: Propofol; short-acting neuromuscular blockade.
- Maintenance: Volatile or TIVA; consider pEEG monitoring for depth.
- Analgesia: Multimodal — paracetamol, NSAID, dexamethasone, regional blocks (TAP/ESP) for open or laparoscopic procedures, opioid rescue only.
- Fluids: Goal-directed, balanced crystalloids; avoid overload.
- PONV: Multimodal prophylaxis.
- Temperature: Active warming.
- Urinary catheter: Remove as early as possible — on the day of surgery for minimally invasive surgery and no later than postoperative day 1 for laparotomy, unless contraindicated. Catheters should remain in place for 7 days in patients with elective or traumatic cystotomy or cystectomy.
The ERATIC guidelines represent the first attempt to apply ERAS principles to major trauma and polytrauma — a population with deranged physiology, unpredictable timing, and high mortality. Published in three parts in the World Journal of Surgery, the guideline covers pre-hospital care, resuscitation-room management, intraoperative care, and postoperative ICU care. Thirty-seven aspects of trauma care were considered, with 87% overall agreement on all statements after a modified Delphi process (100% agreement on 31 of the main statement sets).
ERAS principles apply to trauma — with modified expectations. The core ERAS domains (multimodal analgesia, temperature management, goal-directed fluids, early nutrition) remain valid, but the trauma patient's deranged physiology means that strict adherence to elective-surgery fasting protocols or near-zero fluid balance is not appropriate. The guideline explicitly extrapolates from elective surgery where evidence is lacking, and flags these extrapolations as areas needing further evaluation.
Key anaesthetic recommendations for trauma
- Shortened fasting: Clear liquids up to 2 hours before anaesthesia where feasible. In the acute trauma setting, this may not be achievable — do not delay necessary surgery for fasting.
- Balanced anaesthesia: Use balanced techniques with short-acting agents; avoid excessive depth. Maintain normothermia aggressively — trauma patients are at high risk of hypothermia.
- Goal-directed fluid therapy: Avoid both under-resuscitation and fluid overload. Use appropriate haemodynamic assessment and dynamic indices where valid and applicable; interpret them in the context of the patient's ventilation, rhythm, bleeding and overall physiology. Judicious vasopressor use when hypotension persists despite adequate volume.
- Early antibiotic prophylaxis: Timed appropriately for open fractures and penetrating injuries.
- Multimodal analgesia: Opioid-sparing where possible; regional techniques may be appropriate for isolated limb trauma, but consider coagulopathy and compartment syndrome risk.
- Early nutrition: Initiate enteral nutrition within 24–48 hours in ICU patients, unless contraindicated.
The cross-specialty comparison: what differs, what doesn't
For the anaesthesiologist working across multiple specialties, the following table compares the anaesthetic recommendations across the five major guidelines covered in this guide. The universal core remains constant; the specialty-specific modifications are what change.
| Domain | Colorectal | Cesarean | Cardiac | Gyn-Onc | Trauma |
|---|---|---|---|---|---|
| Fasting | Clear 2h / solids 6h | Clear 2h / solids 6h | Clear 2h / solids 6h | Clear 2h / solids 6h | 2h clear where feasible; don't delay |
| Carbohydrate loading | Yes (unless contraindicated) | Yes (unless contraindicated) | Yes — 800 mL 12.5% night before + 400 mL 2h before | Yes (unless contraindicated) | Not applicable in acute trauma |
| Multimodal analgesia | Paracetamol + NSAID + regional (TAP/ESP for MIS; TEA for open) | IT morphine + paracetamol + NSAID + opioid rescue | Paracetamol + NSAID + gabapentinoid + lidocaine infusion ± regional blocks | Paracetamol + NSAID + dexamethasone + regional blocks | Opioid-sparing where possible; regional for isolated limb trauma |
| Fluid strategy | Avoid both hypovolaemia and excess; GDFT; balanced crystalloid | Euvolemia; avoid overload; co-loading for spinal | GDFT; avoid overload | GDFT; balanced crystalloid | GDFT; judicious vasopressors; interpret indices in context |
| Temperature | ≥36°C active warming | ≥36°C active warming | ≥36°C active warming | ≥36°C active warming | Aggressive warming — high hypothermia risk |
| PONV prophylaxis | Multimodal | Dexamethasone + ondansetron | Dexamethasone at induction + ondansetron at end | Multimodal | As indicated |
| Special considerations | Cerebral monitoring (pEEG) where available; avoid deep anaesthesia | Prevent spinal hypotension; phenylephrine infusion from spinal | Lung-protective ventilation; early extubation | Same-day discharge for selected MIS patients; early catheter removal | Modified expectations; deranged physiology |
Cross-specialty comparison of anaesthetic recommendations across the five major ERAS guidelines. The universal core is constant; the specialty-specific modifications are what change.
The BJA systematic review: what it found, why it matters
The 2026 systematic review by Bornemann-Cimenti and colleagues is the most important ERAS publication for anaesthesiologists in the last decade. Its key findings:
- 24 guidelines published between 2013 and 2025 were included in the final analysis. Anaesthesiological involvement was identifiable in 23 of 24.
- Of 45 anaesthesiological umbrella terms, eight were consistent (>80%), ten were mostly consistent (60–80%), sixteen were mixed (20–60%), and eleven were sparse (≤20%).
- The mean AGREE II methodological quality score was 76% — highest for scope/purpose and clarity of presentation, lowest for stakeholder involvement.
- The consistent domains — multimodal analgesia, fasting, thromboprophylaxis, antimicrobial prophylaxis, nutrition, temperature management, fluid management, and surgery-specific recommendations — define the transposable anaesthesiological core.
- Domains with high consistency but mixed recommendation strength — fluid management, preoperative carbohydrate administration, and preanaesthetic medication — warrant structured local appraisal rather than blind adoption.
The practical takeaway
The BJA review confirms what experienced ERAS anaesthesiologists have suspected: there is a core. You do not need to memorise 24 separate guidelines. Learn the eight consistent domains, apply them universally, and then adapt the specialty-specific modifications for each surgical type. The mixed-strength domains are where you should exercise clinical judgment and contribute to local audit.
What this means for your practice
ERAS is no longer a colorectal surgery protocol. It is a perioperative medicine framework that now spans nearly every surgical specialty, and anaesthesiologists are the common thread running through all of them. The universal core — multimodal analgesia, shortened fasting, thromboprophylaxis, antimicrobial prophylaxis, nutrition, temperature, fluid management, and procedure-specific adaptation — is the minimum standard for any ERAS pathway. The specialty-specific modifications are where the art of anaesthesia lives: knowing when to use a TEA and when to use a TAP block, when to start a phenylephrine infusion and when to co-load, when to extubate in theatre and when to fast-track in ICU.
The BJA review has given us the map. The guidelines provide the territory. The anaesthesiologist in the room provides the judgment.
References
- Bornemann-Cimenti H, Furtmüller JM, Labenbacher S, et al. Beyond procedure-specific protocols: a systematic review identifying a universal anaesthesiological core across Enhanced Recovery After Surgery Society guidelines. Br J Anaesth. 2026;137(3). doi:10.1016/j.bja.2026.06.006.
- Gustafsson UO, Rockall TA, Wexner S, et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations 2025. Surgery. 2025;184:109397. doi:10.1016/j.surg.2025.109397.
- Caughey AB, Sultan P, Monks DT, et al. Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 2)—2025 update. Am J Obstet Gynecol. 2025;233(6S). doi:10.1016/j.ajog.2025.02.040.
- Grant MC, Crisafi C, Alvarez A, et al. Perioperative care in cardiac surgery: a joint consensus statement by the Enhanced Recovery After Surgery (ERAS) Cardiac Society, ERAS International Society, and The Society of Thoracic Surgeons (STS). Ann Thorac Surg. 2024;117(4):669-689. doi:10.1016/j.athoracsur.2023.12.006.
- Nelson G, Altman AD, Metcalfe A, et al. Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update. Gynecol Oncol. 2026. (Third updated guideline.)
- Hardcastle TC, et al. Guidelines for Enhanced Recovery After Trauma and Intensive Care (ERATIC): Enhanced Recovery After Surgery (ERAS) Society and International Association of Trauma Surgery and Intensive Care (IATSIC) Recommendations: Paper 1: Initial Care—Pre and Intraoperative Care Until ICU, Including Non-Operative Management. World J Surg. 2025;49(8):1997-2028. doi:10.1002/wjs.70002.
- ERAS® Society. Guidelines. erassociety.org/guidelines/. Accessed Sept 2026.